Automated Parallel Synthesis Accelerates Virtual Screening Hit Discovery
Journal of the American Chemical Society · 2026-07-22 · 148 (28) · 29908-29920
DOI: 10.1021/jacs.6c05055 ↗At a glance
Journal article in Journal of the American Chemical Society, published online on 2026-07-10. Written by Sean M McKenna and 9 co-authors. Institution: Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands. Major MEDLINE topics: Receptors, CCR2, Drug Discovery, Small Molecule Libraries. Cited 2 times so far (Crossref); 69 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Research Council, Oncode Institute, Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy.
Abstract (original language)
Virtual screening (VS) is a powerful approach to exploring a vast chemical space, encompassing libraries of millions to billions of compounds. However, the low hit rates of VS require testing numerous candidates to validate true binders, followed by iterative optimization cycles, which makes experimental validation costly and time-consuming. Here, we report COMBINAUT, an automated parallel synthesis platform that generates diverse chemical scaffolds to accelerate hit validation and refinement. Using a faculty-wide collection of in-house building blocks, the system enables enumeration of over 22.9 million compounds, each designed for parallelized synthesis within 32 h using repurposed solid-phase peptide synthesis equipment. Using this platform, we performed large-scale VS targeting the allosteric pocket of the immuno-oncology target, C-C chemokine receptor 2 (CCR2). Our approach facilitated the rapid synthesis and testing of 100 VS hits spanning diverse molecular architectures. In radioligand binding assays, we successfully validated nine hits with distinct scaffolds, including completely novel CCR2 ligand chemotypes. Iterative hit-to-lead optimization using the automated workflow produced cell-active CCR2 antagonists. This work demonstrates the synergy of automated synthesis and VS, enabling the efficient exploration of chemical space and the rapid discovery of novel ligands.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.
- Oncode Institute, 3521 AL Utrecht, The Netherlands.
- CZ-OPENSCREEN, National Infrastructure for Chemical Biology, Department of Informatics and Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Repu…
ORCID profiles: Martin Šícho, Edith van der Nol, Gerard J P van Westen, Laura H Heitman, Sebastian J Pomplun
Funding
- European Research Council
- Oncode Institute
- Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy
- Oncode Accelerator
- Grantov? Agentura Cesk? Republiky
Cite
APA
McKenna, S. M., Šícho, M., van der Horst, C., Maasland, J., van der Nol, E., Turco, G., Bernatavicius, A., van Westen, G. J. P., Heitman, L. H., & Pomplun, S. J. (2026). Automated Parallel Synthesis Accelerates Virtual Screening Hit Discovery. Journal of the American Chemical Society, 148(28), 29908-29920. https://doi.org/10.1021/jacs.6c05055
Vancouver
McKenna SM, Šícho M, van der Horst C, Maasland J, van der Nol E, Turco G, et al. Automated Parallel Synthesis Accelerates Virtual Screening Hit Discovery. Journal of the American Chemical Society. 2026;148(28):29908-29920. doi:10.1021/jacs.6c05055
BibTeX
@article{McKenna2026,
author = {McKenna, Sean M and Šícho, Martin and van der Horst, Cas and Maasland, Jesse and van der Nol, Edith and Turco, Gianluca and Bernatavicius, Andrius and van Westen, Gerard J P and Heitman, Laura H and Pomplun, Sebastian J},
title = {Automated Parallel Synthesis Accelerates Virtual Screening Hit Discovery},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {28},
pages = {29908--29920},
doi = {10.1021/jacs.6c05055}
}
EUVIMED